Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jan 5, 2017 (10 years ago)

Fluconazole Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications

Cause type: Dissolution failure

The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.

What was recalled

Fluconazole Tablets, USP, 200 mg, 100-count Unit Dose carton, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, Distributed by MAJOR PHARMACEUTICALS, 31778 Enterprise Dr., Livonia, MI 48150 USA, NDC 0904-6501-61

Affected NDC 0904-6501-61

Compare with the code on your package — it is the most precise check available.

Drug: Fluconazole

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Fluconazole
NDC 00904-6501
200 mg/1 Tablet
Oral
Major Pharmaceuticals Rx
Recalling firm
The Harvard Drug Group
NDC code
0904-6501-61
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0689-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Fluconazole recalls

See all
Class III · Low risk

Fluconazole Injection

Superpotent Drug: lots out of specification for elevated sodium chloride and fluconazole assay.

Terminated Wrong potency / content Renaissance Lakewood, LLC D-1033-2018
Class III · Low risk

Fluconazole Injection

Failed Stability Specifications: lot out of specification for elevated water vapor.

Terminated Stability / shelf life Renaissance Lakewood, LLC NDC 36000-002-10 D-1032-2018
Class III · Low risk

Fluconazole Injection

Superpotent Drug and Failed Stability Specifications: lot out of specification for elevated sodium chloride and elevated water vapor.

Terminated Wrong potency / content Renaissance Lakewood, LLC NDC 36000-003-06 D-1031-2018
Class II · Moderate risk

Fluconazole Injection

Labeling: Label mix-up - A complaint was received of one bag of Fluconazole Injection, Iso-Osmotic Sodium Chloride Diluent, USP, 2mg/mL, 50 mL found within the package of 100 mL bags.

Terminated Labeling / mix-up Renaissance Lakewood, LLC NDC 36000-002-10 D-0696-2018

Other recalls by The Harvard Drug Group

All 2017 recalls
Class II · Moderate risk

Omega-3-Acid

Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.

Ongoing Failed specification The Harvard Drug Group LLC D-0493-2026